Spero Therapeutics
SPRO
#8943
Rank
NZ$0.27 B
Marketcap
NZ$4.67
Share price
2.61%
Change (1 day)
284.07%
Change (1 year)

Market capitalization of Spero Therapeutics (SPRO)

Market cap: NZ$0.27 Billion

As of April 2026 Spero Therapeutics has a market cap of NZ$0.27 Billion. This makes Spero Therapeutics the world's 8943th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Spero Therapeutics from 2017 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.27 B19.86%
2025NZ$0.22 B126.67%
2024NZ$99.56 M-19.18%
2023NZ$0.12 B-12.68%
2022NZ$0.14 B-81.42%
2021NZ$0.75 B-3.44%
2020NZ$0.78 B187%
2019NZ$0.27 B73.68%
2018NZ$0.15 B-33.64%
2017NZ$0.23 B

End of Day market cap according to different sources

On Apr 19th, 2026 the market cap of Spero Therapeutics was reported to be:

NZ$0.27 Billion
by Nasdaq info icon info icon
NZ$0.27 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
IBM
IBM
NZ$404.16 B 149,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Thomson Reuters
TRI
NZ$70.00 B 25,779.10%๐Ÿ‡จ๐Ÿ‡ฆ Canada
Franklin Covey
FC
NZ$0.46 B 71.11%๐Ÿ‡บ๐Ÿ‡ธ USA